EyeGate Pharmaceuticals, Inc. / Estimates

    Fiscal Year Revenue Net income Net margin Free cash flow FCF margin
    €13.80M +132,746.8% €6.65M -195.5% 48.2% +670 pp €7.38M -219.2% 53.5% +600 pp
    €10.38K -99.6% -€6.97M +14.0% -67,102.9% -670 pp -€6.19M -11.9% -59,568.6% -590 pp
    €2.31M +62.5% -€6.11M -34.4% -264.2% +3.9 pp -€7.02M -22.9% -303.6% +3.4 pp
    €1.42M +305.5% -€9.31M -18.2% -654.2% +26 pp -€9.11M +64.4% -639.9% +9.4 pp
    €350.95K -39.1% -€11.38M -0.9% -3,243.5% -12 pp -€5.54M -23.5% -1,578.2% -3.2 pp
    €576.35K +∞% -€11.49M +59.0% -1,993.8% -20 pp -€7.24M +88.4% -1,255.4% -13 pp
    €0.00 +NaN% -€7.23M +373.1% N/A -€3.84M +369.1% N/A
    €0.00 +NaN% -€1.53M -54.3% N/A -€818.65K -67.9% N/A
    €0.00 +NaN% -€3.34M -35.7% N/A -€2.55M -43.4% N/A
    €0.00 -€5.20M N/A -€4.50M N/A

    Notifications